International vaccine institute to establish a branch in Rwanda

The agreement, signed on Tuesday, June 11, 2024, aims to foster cooperation between the two countries.

This agreement comes at a time when Rwanda is constructing the BioNtech plant, which will manufacture various vaccines.

IVI is a non-profit organization dedicated to advocacy for vaccine availability and accessibility for all, through collaboration with research institutions, governments, and pharmaceutical companies.

The organization plays a role in the development of new vaccines, testing, and distribution worldwide.

Founded in 1998, IVI is headquartered in Seoul, South Korea.